Podcasts about Health economics

Your football team keeps losing. The season is slipping away. One thing can be changed by Friday, and the crowd is already singing about it: sack the manager.Jan van Ours (Erasmus School of Economics, CEPR, Feyenoord fan) has looked at seven seasons of the Dutch top flight and 31 managers who were sacrificed mid-season. To work out whether any of them deserved it, he uses bookmaker odds and expected goals to distinguish bad play from bad luck. The new-manager bounce is real: results improve after a new manager walks in. But also, not real: clubs that don't sack the manager have an upturn too. The message for the boardroom, in football and business, is that not doing anything might often be the best course of action.The research behind this episode:van Ours, Jan C. 2026. "Dust in the Wind: Causes and Consequences of Managerial Replacements." CEPR Discussion Paper DP21850, Centre for Economic Policy Research. The paper is gated.To cite this episode:Phillips, Tim, and Jan van Ours. 2026. "Does sacking the manager work?" VoxTalks Economics (podcast).About the guestJan van Ours is Emeritus Professor of Applied Economics at Erasmus School of Economics, Erasmus University Rotterdam, and a core member of the Erasmus Centre for Applied Sports Economics. He is also Adjunct Professor at the Center for Health Economics, Monash Business School, and a Research Fellow of the Centre for Economic Policy Research. His research spans unemployment dynamics, labour market policy, health and well-being, and the economics of professional sport, where match data offer a rare chance to watch a labour market in the open.Research cited in this episodeThe Eredivisie sample. Seven seasons of the top league of Dutch professional football, from 2018/19 to 2024/25, covering 4,136 match observations and 126 club-seasons. In that period 31 managers were replaced during a season; about 15% had gone by mid-season and 25% by the end of it.Points surprise. The cumulative gap, from the first match of the season, between the points a club has won and the points the bookmakers implied it should have won. Bookmaker odds are used as the benchmark because they already contain everything the market knows about squad quality, home advantage and the opposition; van Ours confirms this in the data, finding that recent results add nothing to the odds as a predictor of the next match.Performance surprise. The same cumulative gap, but measured with expected points derived from expected goals rather than actual results. Points surprise catches a club that is losing. Performance surprise catches a club that is playing badly. A club can be one without being the other, which is how luck gets separated from ability.Expected goals. The probability that a given shot becomes a goal, estimated from thousands of comparable attempts and conditioned on the distance and angle of the shooter, the body part used, and the type of pass and attack. Van Ours converts expected goals scored and conceded into a distribution of match outcomes, and from that into expected points. His data come from fbref.com; the paper notes that match-level expected goals were discontinued in January 2026 after a dispute between fbref and Opta.The counterfactual replacement. The device that carries the paper. For each actual sacking, van Ours searches the same club in a different season for a moment when the sum of points surprise and performance surprise was almost identical, and the manager survived. Of the 31 replacements, 22 have a counterfactual, 19 of them unique. Clubs that sacked the manager gained 0.21 points per match afterwards. Clubs in the same trouble that did not sack the manager gained 0.38.Scapegoating. William Gamson and Norman Scotch set out the idea in "Scapegoating in baseball" in the American Journal of Sociology in 1964, describing the sacking of a manager as an anxiety-reducing ritual that participants treat as an improvement whether or not anything improves. Van Ours returns to it to explain why a decision with no measurable effect keeps being taken.Managers in regular firms. Stuart Gilson's 1989 study in the Journal of Financial Economics found that replaced executives were not employed by another firm for at least three years. Football managers are frequently back in work within weeks, which is one reason the job pays what it does. Hilger, Mankel and Richter reviewed 91 studies of top executive dismissals published between 1960 and 2010 and concluded that the effects of managerial turnover are not statistically different from zero.Related reading on VoxEU.orgWhat we can learn about economics from professional sport during COVID-19, a VoxEU column on why sport keeps producing clean natural experiments for economists.Racial bias in newspaper ratings of professional football players, a VoxEU column using match ratings to test for discrimination in a labour market where output is measured in public every week.

Toyota didn't beat Mercedes by getting cheaper. It beat Mercedes by getting closer to the customer first. Here's the six-year research obsession behind the Lexus LS 400, and why undercutting your way to a full panel is a strategy that has already failed in a dozen other industries, and what Harvard's own pricing research says to do instead. By Michael Tetreault, Editor-In-Chief, Concierge Medicine Today "I'm a car guy, so bear with me on this one. There will be some good points [in this article], I promise. I know enough about engines to self-diagnose and wrench on them myself. Driving an old car with lifter problems through North Dakota and southern Canada in the '90s will teach you that." ~Michael Tetreault Today's article isn't about concierge medicine directly. It's about a distant cousin in the subscription-based healthcare world, direct primary care, or DPC. Over the past two decades, I've noticed more and more that there is a moment almost every DPC or low-cost, membership-based practice hits around year two or three, when the patient panel quietly stalls (catch the car pun). Growth that used to feel automatic starts to flatten out, and you notice it before you can quite explain it. That's usually right about when a competitor down the road launches at $59 to $93 a month, and a quiet voice in your head says: just drop the price. Fill the seats. Worry about margin later. That instinct is understandable. It is also, according to decades of business research and a growing body of data inside concierge and membership medicine itself, one of the fastest ways to damage the very practice you built to serve patients better. This is not a scolding. It is a strategy conversation, grounded in evidence, for low-cost subscription-based physicians who left, or are considering leaving, the insurance-driven system specifically to build something sustainable that has a low cost for the patients because you feel your altruistic nature pulling you to do so. But, if the goal is sustainability, the tactic matters. What "racing to the bottom" actually means Let's zoom out for a moment. A price war is what happens when competitors inside the same market repeatedly cut prices to undercut one another, creating a cycle where each side matches or beats the last cut. This "price-cutting momentum" pulls in competitors who feel forced to follow the initial price cut, and while it can create short-term benefits for the buyer, it erodes the profit margins of everyone competing. Harvard Business School researchers Akshay Rao and Mark Bergen, writing in Harvard Business Review, built a career studying exactly this dynamic across industries. Their conclusion, echoed by strategists since, is blunt: most price wars are avoidable, and the businesses that start them or get pulled into them rarely come out ahead. The Kinsta business blog, summarizing HBR's own internal analysis of the question, put it plainly: when businesses were asked whether they should engage in a price war, the overwhelming answer was "no." Instead, the research points toward differentiation as the more durable response to a low-cost competitor. There is a second, quieter finding in that same research that some physicians should sit with. Price itself shapes how a buyer perceives value, and a price set too low signals that the product is cheap, in the way a price set too high can signal it is a ripoff. In other words, the discount that was supposed to win the patient can be the very thing that tells the patient your care is not worth much. It's indeed, a delicate balance and it's different for every practice and every doctor. Why? Because of who you work for and serve: the patient. Every patient is different. Every practice is different. That makes this topic challenging but it's a conversation worth having because I want to see your practice thrive and more importantly, survive in your community. The framework underneath the instinct Michael Porter, the Harvard strategist whose work still anchors most first-year MBA curricula, described three durable paths to competitive advantage: cost leadership, differentiation, or a focused niche strategy. A company chooses to compete either through lower costs than its rivals or by differentiating itself along dimensions the customer actually values, in order to command a higher price. What Porter warned against was the position most panic-driven price cuts land a practice in. Porter's phrase for it is "stuck in the middle," and it describes an organization trying to be all things to all people, with no distinct competitive advantage as a result. Businesses caught here typically perform the worst in their industry precisely because they never committed to one strength. A DPC practice that quietly lowers its price to compete on cost, while still trying to deliver same-day access, unhurried visits, and so-called affordable white-glove service, is not competing on cost leadership. It is trying to sell a premium product at a discount price, and the math does not hold. Today, a medical practice or a company stuck in this position cannot beat a true cost leader on price, because it never built the operational discipline or scale to sustain that price, and it cannot beat a differentiator on the experience it promised, because the discipline required to deliver that experience costs money. Both promises erode at once. What the data inside DPC and low-cost membership medicine is already showing This is not theoretical for DPC and low-cost membership medicine practices. It is visible in the industry's own numbers. The 2026 State of DPC survey, distributed through the DPC Alliance and Hint Health's network, found a direct relationship between panel size and price. Practices with fewer than 200 patients averaged $105.93 per member per month, practices with 201 to 500 patients averaged $99.28, and practices with more than 500 patients averaged $77.74 per member per month. Read plainly, the larger the panel, the lower the average price charged per patient. That pattern is exactly what Porter's framework predicts happens to practices chasing volume without a differentiation strategy to protect price. It is worth noting this figure comes from Hint Health, a technology vendor with a commercial interest in DPC's growth, so it should be read as directional industry data rather than an independent audit. It is nonetheless the most comprehensive dataset the movement currently has. At the same time, the broader market is not short on room to compete on value instead of price. More than half of private healthcare consumers rank the cost of care as the most dissatisfying part of their current healthcare experience, and DPC's growth has been driven in large part by employers and patients who are tired of opaque, escalating costs elsewhere in the system, not by DPC being the cheapest option on paper. Employers now fund the majority, roughly 60 percent, of active DPC memberships, according to Hint Health's 2026 trends report, which signals that the buyers filling panels today are increasingly sophisticated purchasers evaluating value, retention, and outcomes, not simply hunting for the lowest sticker price. Regional pricing tells a similar story. Northeast DPC pricing rose 33 percent over five years, from $60 to $80 a month, even as national demand for the model accelerated. Practices in that region did not grow by discounting. They grew while raising price, in a market that was simultaneously expanding. The altruism problem no one names out loud Here is the part of this conversation that is specific to medicine and does not show up in a typical business school case study on price wars. Physicians are trained, deliberately and repeatedly, to put the patient's welfare ahead of their own. Medical professionalism itself is defined in the literature by principles of excellence, accountability, altruism, integrity, and humanism, all oriented around the patient relationship. That formation is not incidental. It is the point of medical education, and it is a genuine strength of the profession that should never be coached out of a physician. But that same formation has a side effect worth naming honestly. A rigorous study out of the University of Cologne and University of Rennes, published in the Journal of Health Economics, measured patient-regarding altruism in 733 medical students at different stages of training. The researchers found that patient-regarding altruism is highest among freshmen, declines significantly through the middle years of medical study, and rises again in the final year as students begin assisting in clinical practice. Students with lower income expectations showed higher altruism scores overall. Sit with that last finding. The training that makes physicians excellent, trustworthy, patient-first clinicians also correlates with a documented discomfort around charging what care is actually worth. That discomfort is admirable in the exam room. It becomes a strategic liability in the business office, where it quietly nudges a physician toward the lowest defensible price rather than the price that reflects the value delivered, the access provided, and the sustainability required to keep serving that same patient for the next twenty years. This is not a call to abandon altruism. It is a call to separate two different questions that get tangled together under stress: am I a good doctor and am I running a sustainable practice. A price built out of guilt is not more altruistic than a price built out of strategy. A closed practice serves no one. What other industries learned the hard way Medicine is not the first field to face this exact temptation, and the businesses that raced to the bottom on price rarely tell a happy ending. Rao and Bergen's HBR research spans industries from B2B and agribusiness to healthcare and the nonprofit sector, and the throughline in that body of work is consistent: firms that respond to a low-price competitor by cutting their own price usually shrink the whole market's profitability without gaining durable share, because the competitor simply cuts again. The winners in price wars, when there are any, tend to be the largest players with the deepest balance sheets, the ones who can absorb losses the longest. A solo or small-group physician practice is almost never that player, and should not try to be. The lesson for low-cost DPC physicians is not abstract. It is Porter's choice, stated as a decision every practice has to make deliberately rather than by drift: compete on being demonstrably, operationally the lowest-cost, highest-efficiency provider in your market, which requires real scale and real systems, or compete on being demonstrably different in a way patients value enough to pay for. Trying to hold both at once is what leaves a practice, in Porter's words, stuck in the middle, with margins too thin to sustain the very things that made the practice worth choosing in the first place. The Lexus Lesson: Price Is a Result, Not a Strategy Circling back to my car guy roots, there is an automotive story worth every physician's attention here, because it is one of the clearest business case studies ever produced on the exact question this article is asking you if you're a DPC physician. It comes from Hagerty's "Revelations" series, hosted by Jason Cammisa, on the origin of the 1989 Lexus LS 400, and it has been retold in detail across automotive trade press and in Chester Dawson's book Lexus: The Relentless Pursuit. The origin story matters as much as the engineering. Toyota's first American export, the Toyopet Crown, was a flop, selling only a few hundred units before Toyota pulled it from the market in the late 1950s. Twenty five years of steady rebuilding later, Toyota had become the largest importer of vehicles into the United States, and that success triggered a protectionist response. In the early 1980s, the U.S. government pressured Japan into so-called voluntary export restraints, capping Japanese auto imports at roughly 1.7 million vehicles a year. With volume capped by government policy, Toyota USA's Yukiyasu Togo pushed a different lever: if the company could not sell more cars, it needed to sell more profitable ones. That constraint, not ambition alone, is what pushed Toyota into the luxury segment. In 1983, Toyota's then chairman Eiji Toyoda greenlit a secret effort known as Project F1, for Flagship One. Where a typical vehicle program of that era might use around 200 engineers and a few hundred million dollars, F1 was reportedly given no fixed budget and a development team of roughly 1,400 engineers, 60 designers, and thousands of additional technicians and support staff, spread across a six-year effort widely reported to have cost in the neighborhood of a billion dollars. What that team actually did is the part physicians should study closely. Rather than guess at what luxury buyers wanted, a team of designers and engineers relocated to a rented house in Laguna Beach, California, and spent months directly observing affluent Americans: watching valet stands outside country clubs, studying the furniture in high-end homes, and even analyzing the leather scent inside Jaguar interiors closely enough to reverse-engineer the tanning process. They tested switchgear and steering wheel ergonomics against how women with long, manicured nails actually interact with a dashboard. This is the practice Toyota calls genchi genbutsu, going to see for yourself, rather than relying on assumptions about the customer. Separately, Toyota's research uncovered something more specific and more useful than "people want a cheaper luxury car." Mercedes-Benz owners loved the prestige of their cars but consistently described the dealership experience itself, the pressure, the wait, the sense of being talked down to, as miserable. Lexus rebuilt the entire buying experience around that single insight. Sales moved from an elevated desk to a shared coffee table, removing the physical power imbalance of a traditional car sale. Only 80 of roughly 1,500 dealer applicants were approved to sell the car, each required to invest several million dollars and submit to ongoing customer satisfaction audits. The product and the experience of buying it were treated as a single, inseparable offer. The engineering discipline underneath all of this was, by most independent accounts, extreme. Chief engineer Ichiro Suzuki pursued a drag coefficient of 0.29, well below the S-Class's 0.36 to 0.37, without relying on a rear spoiler, which he considered an inelegant shortcut. Interior noise was engineered down to roughly 58 decibels versus about 60 for the S-Class, and multiple road tests reported the LS 400 was as quiet at 125 miles per hour as its German rivals were at 95. Prototypes logged well over a million miles of testing, and engineers reportedly disassembled competitor vehicles to study exactly how they failed over years of use, then engineered around each weakness. When the LS 400 launched in 1989, it was priced at roughly $35,000, commonly cited as about half the price, or as much as $30,000 less, than a comparably equipped Mercedes-Benz S-Class. The price gap was so large that BMW reportedly suggested Toyota was selling the car at a loss. Within two years, Lexus had overtaken Mercedes-Benz as the best-selling luxury import brand in the United States and topped J.D. Power's quality and service rankings, and Mercedes is reported to have lost roughly a quarter of its U.S. sales in the aftermath. Here is the part physicians should sit with. The low price was not the strategy. It was the output of the strategy. Toyota did not set out to build a cheaper Mercedes and work backward. It spent six years and enormous resources removing the specific frustrations its own research showed were driving prestige-loving customers away, then engineered a manufacturing process disciplined enough to make that quality repeatable at scale, and only after that work was done did it set a price the market would reward. The aggressive price was possible because the operational excellence and the customer research underneath it were real, not because anyone at Toyota decided to compete by cutting corners. This is the distinction that gets lost when a DPC or low-cost membership medicine practice drops its membership fee simply to fill a panel out of fear. Toyota's price was earned through relentless, well-funded engineering and firsthand study of exactly what its target customer resented about the existing options. A practice that lowers its price without first doing that same work, actually going to see for yourself what frustrates the patients you want to serve, and building a practice that removes those specific frustrations, is doing the opposite of what Lexus did. It is cutting the price before it has earned the right to. The translatable lesson is not "charge less." It is this: find out, directly and specifically, what your patients are actually frustrated by in the healthcare experience they already have, build a practice that removes that frustration with real discipline, treat the entire patient experience, not just the clinical visit, as part of the product, and let price follow from that work rather than substitute for it. Toyota spent six years in the field before it touched the price tag. Most practices considering a discount have not spent six weeks asking patients what specifically is broken in the care they are currently getting. What to build instead None of this means price is fixed or that access should be reserved only for the wealthy. It means the starting question changes. Instead of asking what is the lowest price that will fill my panel, the more durable question is what does my practice do that a patient cannot get anywhere else in this market, and does my price reflect that honestly. That might be same-day access. It might be visit length. It might be a specific clinical focus, a specific population, or a specific relationship to a local employer. Differentiation does not require the highest price in the market. It requires a clear, honest reason for the price you have chosen, one you can say out loud to a patient without flinching. Panel growth built on discounting tends to attract patients who are price-shopping and will leave the moment a cheaper option appears next door. Panel growth built on a clear, differentiated value proposition tends to attract patients who stay, refer, and tolerate a price increase because they understand what they are paying for. This article is intended for educational and informational purposes for physicians and healthcare leaders. It does not constitute financial, legal, accounting, or medical advice, and practice pricing decisions should be made in consultation with qualified financial and legal advisors familiar with your specific market and regulatory environment. Sources Rao, Akshay R. and Bergen, Mark E. "How to Fight a Price War." Harvard Business Review, March-April 2000. hbr.org/2000/03/how-to-fight-a-price-war "Price war." Wikipedia, accessed August 2026. en.wikipedia.org/wiki/Price_war "How a Race to the Bottom Hurts Your Business's Bottom Line." Kinsta, July 15, 2024. kinsta.com/blog/race-to-the-bottom Porter, Michael E. Competitive Strategy (1980) and Competitive Advantage (1985), Harvard Business School Press. Summarized via "Porter's generic strategies," Wikipedia, and Strategic Management Insight, strategicmanagementinsight.com/tools/porters-three-generic-strategies "State of DPC 2026: Key Takeaways From DPC Alliance's Physician Survey." Hint Health, July 18, 2026. blog.hint.com/state-of-dpc-2026-key-takeaways-from-the-dpc-alliances-physician-survey "Hint Health Releases 2026 Direct Primary Care Trends Report." Hint Health, April 23, 2026, distributed via PR Newswire, Yahoo Finance, and Morningstar. "DPC Membership Pricing Trends." Hint Health Blog, June 24, 2022. blog.hint.com/dpc-membership-pricing-trends "High cost of health care may be boosting direct primary care membership." Medical Economics, November 16, 2025. medicaleconomics.com/view/high-cost-of-health-care-may-be-boosting-direct-primary-care-membership Sagebien, Julia; L'Haridon, Olivier; Wiesen, Daniel; et al. "The formation of physician altruism." Journal of Health Economics, Vol. 87, 2023. sciencedirect.com/science/article/pii/S0167629622001308 (also indexed on PubMed, ID 36603361) "Professional identity formation of clinical medical students during and beyond the pandemic." PMC, National Library of Medicine. pmc.ncbi.nlm.nih.gov/articles/PMC11150932 Cammisa, Jason. "The Absurd Engineering Obsession Behind the 1989 Lexus LS 400." Hagerty Revelations, YouTube, youtu.be/i15Ii4yetLM "How the Lexus LS400 Crashed the Luxury Party." Autoblog, October 2, 2025. autoblog.com/features/how-the-lexus-ls400-crashed-the-luxury-party "How Lexus defeated 'the best car in the world.'" Motoring Research, July 25, 2024. motoringresearch.com/car-news/lexus-ls-400-review "Lexus LS 400: 'the finest V8 engine in the world.'" Cult Classics, Adrian Flux, August 21, 2023. adrianflux.co.uk/cult-classics/lexus-ls-400-the-finest-v8-engine-in-the-world Dawson, Chester. Lexus: The Relentless Pursuit. John Wiley & Sons, revised edition. Publisher synopsis via AbeBooks, abebooks.com/9780470828045 A detailed companion recap of the Hagerty Revelations episode, covering Project F1 staffing, the Laguna Beach research house, the coffee-table dealership model, and Suzuki's engineering targets, was supplied directly by the editor. Its original publisher and byline could not be independently confirmed at time of writing. Facts drawn from it (drag coefficient, price gap, engineer count, dealership vetting) were cross-checked against sources 11 through 15 above before inclusion, and the editor should confirm original attribution before publication.

Should a life-saving, but expensive, cancer drug be made available on the NHS even though it only benefits very few people? Or should the money be allocated to drugs that lower blood pressure, which help vast swathes of the population? For the final episode of this season, we spoke to Joe Hilton, a health economist, to understand more about how difficult decisions like this one are made.  Joe is a research fellow in mathematical modelling at the Manchester Centre for Health Economics and a 2025 JUNIPER Fellow. JUNIPER is a network of researchers across the UK working to prepare the country for the public health challenges of the future. We spoke to Joe at JUNIPER's annual meeting to understand more about the role of maths and economics in healthcare. He also talked us through his path into this job and what it was like going into research into health policy in 2020 at the very start of the pandemic!  To find out more about the mathematics of health, you might enjoy: This article about about how mathematical models are used in epidemiology An exploration of how you can use maths to understand disease spread in a hospital Another podcast on how modellers work between maths and medicine Maths on the Move, is the podcast from plus.maths.org. We speak to researchers from the frontiers of mathematical science so you can connect with the maths that shapes and explains our world. Hosted by Plus editors Rachel Thomas and Marianne Freiberger. This podcast is part of our collaboration with JUNIPER, the Joint UNIversities Pandemic and Epidemiological Research network. JUNIPER is a collaborative network of researchers from across the UK who work at the interface between mathematical modelling, infectious disease control and public health policy. You can see more content produced with JUNIPER here.

How surgical devices are cleaned and decontaminated determines the efficacy of the sterilization process. For this to be effective, each item must be cleaned according to its instructions for use (IFU). But, how do manufacturers validate cleaning processes for their instruments? In episode 157, host Casey Czarnowski speaks with Dr. William Levia of Medtronic about the manufacturer validation process. Dr. Levia describes the many detailed steps that manufacturers must go through to test cleaning protocols and the reasons behind them. He refers to the different classes of medical devices and discusses the roles of regulatory agencies, standards-setting organizations and testing laboratories. He also introduces listeners to ANSI/AAMI ST98:2022 Cleaning validation of health care products—Requirements for development and validation of a cleaning process for medical devices. Dr. Levia believes in bridging “the standards, the core science and the real-world setting.” Listen to learn more about how instrument manufacturers do their jobs, so we can do ours. ABOUT OUR GUEST Dr. William Levia Global Senior Program Manager for Sterile Processing Medtronic Dr. William Leiva received his PhD in Cybernetics and Statistics from Bucharest University of Economic Studies in 2024 and his MPH in Epidemiology and Health Economics from Andrés Bello National University in 2018. He has worked as a Senior Manager for Scientific Affairs at 3M Healthcare (2008–2023), sterilization and reprocessing subject matter expert at the FDA, and in a leadership role at Medtronic since 2024. He also holds a visiting professorship at Bucharest University of Economic Studies. Dr. Leiva is a recipient of AAMI's Kilmer Grant, serves as a reviewer of peer-reviewed articles, and has presented internationally, including at AAMI eXchange and WFHSS. His research topics include reusable medical device decontamination, terminal sterilization, sterile barrier systems and reprocessing economic epidemiology.   Earn CE Now

Insulin has been used to treat type 1 diabetes for more than a century but now there is a new treatment being rolled out on the NHS that can delay the onset of the disease for years. Alongside, screening is gathering pace, identifying those that could benefit. So, is this the beginning of a new era for type 1 diabetes treatment? Dima and his mum Elena explain what it was like to be told that he had tested positive for developing type 1 diabetes and what it was like taking part in the trial for this new drug, teplizumab. Parth Narendran, a Professor of Diabetes Medicine at the University of Birmingham, and Consultant Paediatric Endocrinologist Dr Renuka Dias at Birmingham Women's and Children's Hospital, reveal how these changes are transforming treatment. In July, the NHS announced plans to incentivise us to walk a marathon a month by offering vouchers and discounts. But with scant detail on how the plan will actually work, we ask Joan Costa-i-Font, Professor of Health Economics at London School of Economics, what makes schemes like this succeed or fail. Plus, why are horse fly bites so painful? Dr Erica McAlister, an entomologist at the Natural History Museum, explains how the flies break into our skin, while consultant dermatologist Dr Alexandra Banner describes what's happening in our bodies. Presenter: James Gallagher Producer: Hannah Robins

A third of tomorrow's molecules will come from China. Just ten years ago, that figure was three percent. The entire healthcare ecosystem has shifted from a massive potential market into a testing ground for rapid, decentralized execution.The questions goes beyond how to enter this system, but how to keep pace with its relentless evolution.Welcome to Pharma Minds, Summer Series "Executing differently takes courage". I placed this conversation with Guillaume Delmotte in the second position of our series because he brings something the other episodes simply do not have: a systemic reading of execution. In China, execution is not an individual choice but a mode of operation for the state, highly centralized in its objectives and completely decentralized in its application. I chose this discussion to explore what it concretely costs to actually do what you said you would do at a massive, systemic scale. It reveals that large-scale delivery is only possible when partnerships are built for the long term and when you accept that constant adaptation becomes the course itself. Guillaume Delmotte spent twenty years within Ipsen, navigating international leadership roles across Europe, Russia, and most recently China. Operating in a highly fluid, fiercely competitive market of 1.4 billion people, his impossible context was learning to execute without a rigid playbook. He had to navigate the immense tension between capturing an unprecedented volume opportunity and facing brutal price pressures, all while reinventing patient pathways from the ground up alongside local players.In this episode, we cover:◾️Geography Commands Strategy : Why adapting tactics to localized provincial health policies is the only way to scale.◾️The Virtual Hospital Shift : How digitized care pathways and AI are managing patient flows for minor and severe pathologies.◾️Breaking the Pricing Rules : Moving away from rigid formulation constraints to establish entirely new value models.◾️Building True Ecosystems : Leveraging local distributors and pharmacy data mining to find undiagnosed rare disease patients.◾️The Innovation Mirage : Balancing incredible volume potential with aggressive price cuts and volume-based procurement.The final objective remains clear. The path to get there changes every single day. Those who stop moving lose the market. 

Known for his use of devolved powers, during his tenure as Mayor of Greater Manchester, Andy Burnham now has the opportunity to bring his local blueprint to the national stage. But what does this mean for the future of health and social care? Our panel explore the deeply rooted health inequalities tied to the social determinants of health, the disconnect between local decision-making and national infrastructure, and the urgent need to extend the ability to access social care to more of England's population. We're joined by Michael Marmot: Professor of Epidemiology and Public Health at University College London (UCL) and author of the landmark Marmot Review. Sarah Woolnough: Chief Executive of the health think tank, The King's Fund. Matt Sutton: Professor of Health Economics at the University of Manchester. Reading List Devolution can create new opportunities for better health Will devolving powers to mayors close England's health gap? Andy Burnham's goal of good growth could be a health-creating mission that supports environmental action The King's Fund responds to Andy Burnham's comments on social care 

Send us Fan MailSpencer Perry, PhD, is an assistant professor of Economics and Public Policy at the Institute for Social and Economic Research (ISER) at the University of Alaska Anchorage. Before earning his PhD in Economics at Arizona State University in Tempe, he worked for three years at the Federal Reserve. He moved to Anchorage a year ago when he began his job at ISER where he focuses on topics in health and public economics.This episode was recorded on January 30, 2026.  

It didn’t always cost this much and deliver this little. Something broke in the early 1980s—and in AMERICA’S WRONG TURN: US Health Care in the Neoliberal Era (Johns Hopkins University Press, August 11, 2026 . You can use Promo-Code of HTWN at checkout to get 30% discount ), John E. McDonough explains exactly what it was. The failings of the American healthcare system didn’t happen by accident. They happened because its already sprawling, fragmented structure—Medicare, Medicaid, employer-sponsored insurance, the VA, and more—left it uniquely exposed to a de-regulatory wave that moved fast and largely out of public view. A bedrock faith in free markets was let into the hen house, and the results are stark: the U.S. now spends more and delivers worse outcomes than any other wealthy nation on earth. John McDonough watched neo-liberal economic agenda reshape American political thinking—often without recognizing the seismic nature of the shift in the moment. Its narrow focus on economic and business interests altered government’s role, drove consolidation across industries, deregulated the healthcare sector, and shifted corporate priorities away from consumer benefit and toward shareholder returns. [ dur: 36 mins. ] John McDonough is a professor at the Harvard T.H. Chan School of Public Health and a former Massachusetts state legislator who served thirteen years in the 1980s and 1990s as neo-liberalism was overtaking American political life. He has also co-authored Overcoming the Digital Divide in Health Care AI. Then, many observers argue, that the economic forces are corrupting medical care and eroding the trust between patients and their doctors. The problems in health care delivery have wide implications related to how health care should function particularly when there are limited resources. We examine the ethics of medicine and healthcare, and the modern day issues that complicate them. [ dur: 22 mins. ] Note: this segment is an excerpt from interview recorded on January 16, 2015. The complete version can be found here. Thomas Pogge is the Director of the Global Justice Program and Professor of Philosophy and International Affairs at Yale University. His books include World Poverty and Human Rights and Freedom from Poverty: Who Owes What to the Very Poor?. Martin Wilkinson is Professor of Politics and International Relations at the University of Auckland. His books include Freedom, Efficiency and Equality and Ethics and the Acquisition of Organs. Richard Cookson is Professor at the Centre for Health Economics, and Co-Director of the Equity in Health Policy (Equipol) research group at the University of York. His books include The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making and Jonathan Bradshaw on Social Policy: Selected Writings 1972-2011. This program is produced by Ankine Aghassian, Doug Becker and Sudd Dongre. Health, Politics and Activism, Healthcare Industry, Medicine, neo-liberal economics

Dr. Beth Beaudin-Seiler is a Project Director in the Health Research and Insights practice area, where she leads the Health Economics and Policy team. She leads a portfolio of work that focuses on health care affordability, including the Consumer Healthcare Experience State Survey (CHES) - a survey designed to understand the burdens, trade-offs, and worries respondents have regarding affording health care. Her goal is to educate listeners on the findings of the 2025 TN CHES Survey.https://healthcarevaluehub.org/consumer-healthcare-experience-state-survey/1:38 Beth's backstory from the College of Aviation at Western Michigan University, training pilots to researching healthcare at Altarum.What is Altarum?A nonprofit organization that focuses on improving the health of individuals who have fewer financial resources, or are disenfranchised by the system. Altarum works on behalf of federal, state, and philanthropic organizations on evidence-based research , planning, and implementing different strategies to address healthcare affordability. I am the senior manager of our health economics and policy program area, under our Health Research and Insights Division at Altarum.728 What is the CHES Survey, and what are its findings?CHES survey stands for the Consumer Healthcare Experience State Survey. In 2018, when we started CHES, because we've kind of felt like the healthcare system could be a lot like playing chess. It's difficult to navigate. The CHES survey asks about respondents' experiences with the healthcare system. Not only their experience in navigating it, their confidence in being able to navigate it, what they have experienced in terms of affordability burden, have they had to make trade-offs in terms of trading off food or housing or basic necessities in order to pay for a medical service or medical procedure or a test or their medications, whether or not they're worried about affording medical services both now and in the future. We ask about their levels of trust and respect in the system, and how they feel they've been treated in the healthcare system.10:24 CHES Survey was presented at a Tennessee Justice Center webinar11:17 How often do Tennesseans ration their medications?13:38 Health care affordability concerns for individuals with disabilities?16:13 When people with insurance choose to forgo care because of high deductibles and copays.17:41 How should research like the CHES survey be utilized by parent advocates and healthcare providers that support this community? 22:23 Next Steps?The  CHES survey has been conducted in 36 unique states in the US to form a national database. Findings need to be aggregated to benchmark individual state performance.

Friday, June 19, 2026 - Week 25   June 21 is SYNGAP1 Awareness Day, but we have made it SYNGAP1 Awareness month!  Why 6/21? Because 6p21.32  Donate!  cureSYNGAP1.org/Donate    #ThisIsOursToLose & #BurdenHopeProgress watch #S10e208 https://curesyngap1.org/podcasts/syngap10/tony-update-thisisourstolose-more-great-results-from-camp4-nightofimpact-in-9-days-s10e208/    New family email, very good, lots of questions.  It's all here.  Reach out, we are here for you and you are welcome in this community – you are part of it whether you like it or not. Raise money.  Join our host committee for 2nd SF event next year. Believe that we are doing the best we possibly can, and you would be adrift without a PAG.  If you think this is painful, imagine if we weren't here! Register for the Conference.  Book tickets to DEN now.  cureSYNGAP1.org/Denver Join us -- make this org better for all of us and all our kids for all their lives.   Complex work doesn't fit neatly in 10 minutes anymore... Health Economics and Market Access work is going well, we will put out an RFP shortly.   NATURAL HISTORY Goes On!  Make sure you are in it. https://curesyngap1.org/resources/studies/syngap1-prommis/ Orlando/McKee Grant "Validating Remote Developmental Assessments in SYNGAP1-Related Disorders" cureSYNGAP1.org/PR49    

Veja também em youtube.com/@45_graus Céu Mateus é professora catedrática de Economia da Saúde na Division of Health Research na Universidade de Lancaster, Reino Unido. É doutorada em Economia da Saúde Pública, mestre em Política Social Europeia e licenciada em Economia. Foi professora auxiliar de Economia da Saúde na Escola Nacional de Saúde Pública (2001-2014). Trabalhou no Instituto de Gestão Informática e Financeira (hoje ACSS) do Ministério da Saúde no departamento de Desenvolvimento de Sistemas de Informação Gestão entre 1995 e 2001, onde foi a responsável executiva pelo Sistema de Financiamento/Sistema de Classificação em Grupos de Diagnósticos Homogéneos. Enquanto investigadora trabalha principalmente na área de avaliação económica de tecnologias de saúde, medição da eficiência, equidade e qualidade de vida. É presidente da EuHEA – European Association of Health Economics. -- Inquérito aos ouvintes do 45 Graus _______________ Índice (2ª Parte): Serviço Nacional de Saúde: forças e fraquezas Sobrecarga nas urgências Pior em Lisboa e Vale do Tejo O impacto do Dr Google (e Dr ChatGPT) na nossa relação com os cuidados de saúde Faltam camas para internamentos? Demora nas especialidades cirúrgicas vs médicas Internamentos “sociais” Rede de cuidados continuados Cuidadores informais Que medidas recomenda a Céu para melhorar o SNS? Os enfermeiros deviam ter um papel mais relevante no sistema PT? Local de residência e distância à urgência Os imigrantes podem usar o SNS?See omnystudio.com/listener for privacy information.

Veja também em youtube.com/@45_graus Céu Mateus é professora catedrática de Economia da Saúde na Division of Health Research na Universidade de Lancaster, Reino Unido. É doutorada em Economia da Saúde Pública, mestre em Política Social Europeia e licenciada em Economia. Foi professora auxiliar de Economia da Saúde na Escola Nacional de Saúde Pública (2001-2014). Trabalhou no Instituto de Gestão Informática e Financeira (hoje ACSS) do Ministério da Saúde no departamento de Desenvolvimento de Sistemas de Informação Gestão entre 1995 e 2001, onde foi a responsável executiva pelo Sistema de Financiamento/Sistema de Classificação em Grupos de Diagnósticos Homogéneos. Enquanto investigadora trabalha principalmente na área de avaliação económica de tecnologias de saúde, medição da eficiência, equidade e qualidade de vida. É presidente da EuHEA – European Association of Health Economics. -> Nota de correção: Na introdução digo que o último Inquérito Nacional de Saúde foi realizado em 2019, mas a verdade é que foi feita uma nova recolha em 2025 (cujos dados ainda se encontravam em tratamento à data da gravação). _______________ Índice (1ª parte): Como está a saúde em Portugal em comparação com outros países? Estudo da OCDE / Comissão Europeia Diferenças entre homens e mulheres Inquérito Nacional de Saúde: último em 2014, PCP propôs novo Desigualdades económicas Diferenças de PIB entre países PT é dos países com mais altas taxas de vacinação Porque há cada vez mais pessoas anti-vacinas? Depressão e ansiedade Relação entre falta de sensação de controlo sobre a vida e saúde mental Sector da saúde em Portugal Público vs privado Adse e outros subsistemas O peso crescente dos seguros de saúde Porque estamos a gastar mais em saúde? O caso das ecografias See omnystudio.com/listener for privacy information.

The No Surprises Act was designed to protect patients from unexpected medical bills, but nearly four years after the law took effect, many experts say parts of its implementation aren't working as intended. Insurers, hospitals, physician groups and federal regulators continue to battle over the law's payment dispute process, raising questions about whether one of the nation's most significant health care consumer protection laws is achieving its goals.In this special live episode of Tradeoffs, host Dan Gorenstein moderates a conversation with three leading experts on surprise medical billing, health insurance regulation and federal health policy. They explain how the No Surprises Act was implemented, how litigation has shaped the arbitration process, why providers have won a disproportionate share of payment disputes and what policymakers could do to improve the law.Guests:Zack Cooper, Associate Professor of Public Health and of Economics, Yale University; Director of Health Policy, Tobin Center for Economic Policy; Director, Health Care Affordability Lab at YaleBenjamin Chartock, Assistant Professor of Economics, Bentley UniversityLindsey Murtagh, Senior Fellow in Health Services, Policy and Practice, Brown University School of Public HealthRachel Werner, Executive Director, Leonard Davis Institute of Health Economics; Professor of Medicine, Perelman School of Medicine, University of PennsylvaniaLearn more: Read the full reporting and explore additional resources on our website.Want more Tradeoffs? Join more than 5,500 readers who trust Tradeoffs for clear, deeply reported health policy insights. Sign up for our free weekly newsletter.Tradeoffs helps you cut through the noise with clear, deeply reported journalism on the forces driving health care's toughest choices — reporting you won't find anywhere else. If our work helps you stay informed, support it with a donation today. Hosted on Acast. See acast.com/privacy for more information.

A non-invasive Alzheimer's therapy is moving closer to patients, and it could reshape how brain health is treated. In this episode, Christian Howell, CEO of Cognito Therapeutics, joins Saul live at DeviceTalks Boston to discuss how the company is advancing a novel Alzheimer's therapy that uses sensory stimulation through light, sound, and touch. He shares insights from Cognito's HOPE study, the largest non-pharmacologic clinical trial in neurodegenerative disease, involving 673 participants across 70 sites. Christian explains why a strong evidence strategy is essential not only for regulatory approval but also for reimbursement, clinical adoption, and patient access. He also reflects on leadership lessons centered on service, humility, humor, and the importance of aligning stakeholders across the healthcare ecosystem to improve Alzheimer's care. Tune in to hear how Christian Howell and Cognito Therapeutics are working to bring new hope, stronger evidence, and a more accessible path forward for Alzheimer's patients and families! Resources: Connect with and follow Christian Howell on LinkedIn. Follow Cognito Therapeutics on LinkedIn and explore their website.

Health economics is not just about reimbursement. It is about proving how a technology reduces the total cost of care. In this episode, Betty Tsai, President of Cardiology Services International, explains why medtech companies must think beyond existing CPT or MS-DRG codes when shaping their commercialization strategies. Speaking with Saul at the MedTech Innovator event, she highlights how health economics reveals the true cost of a patient journey, from initial admission through readmissions and long-term care. Betty explores how value-based care and CMS performance metrics are reshaping hospital revenue and influencing adoption decisions. She also discusses alternative reimbursement pathways, such as the New Technology Add-on Payment, and emphasizes that companies demonstrating both clinical and economic value are more attractive to providers and investors. Tune in and learn why proving economic value may be one of the most important steps in driving medtech adoption. Resources: Connect with and follow Betty Tsai on LinkedIn.

In this episode of Success Unlocked, Dr. Adrienne Shnier sits down with Olivia, a former AYG client and team member, to talk about her journey from uncertainty and self-doubt to receiving 10 offers and completing her Master of Medical Science in Health Economics at Karolinska Institutet in Stockholm.When Olivia first reached out to Adrienne, she did not feel like the “ideal candidate.” She questioned her experience, compared herself to others, and wondered why a top European medical university would choose her.Through AYG's Mastering Academic Applications program, Olivia learned how to reframe her story, advocate for herself, and build the strongest version of her own application. She also shares how the mindset, scheduling, and peak performance work she learned at AYG helped her once she was actually in the program.From moving to Sweden to navigating a different education system to rewriting major parts of her thesis two weeks before the deadline, Olivia explains how she learned to stop panicking and start planning through pressure.If you have ever questioned whether you belong in the room, this episode will remind you that you do not need to become someone else to succeed. You need the right strategy, the right support, and the confidence to move forward as yourself.What You'll Learn ✔ How Olivia went from self-doubt to 10 offers ✔ Why there is no single “ideal candidate” ✔ How to reframe your experience for stronger applications ✔ Why scarcity mindset can hold students back ✔ What Olivia learned from studying in Sweden ✔ How AYG's mindset work supported her beyond acceptance ✔ The difference between pushing through pressure and planning through it ✔ Why doing hard things on purpose builds real confidenceMastering Academic Applications: From Scratch to Submission is now open for you to complete your applications in 12-weeks! With live coaching, you develop your applications & gain insights into your applications processes like never before. Join us now using this link to enroll!Connect with Adrienne!Looking for support with your graduate or professional school applications? Connect with us at Apply Yourself Global™! Email me personally at adrienne@applyyourselfglobal.com. You can also DM me on Instagram @applyyourselfglobal.Ask the ExpertHave any questions on applications, success, test prep, and more? Send your questions us, or you can submit an audio file via Instagram DM and we can feature you on the podcast!Work with Adrienne

Statin use in the elderly, push for PCSK9 drugs, and pressures on clinicians show how economic interests shape patient care. #StatinsAndSeniors #PCSK9 #DrugMarketing #HealthTalks

The Minister for Health, Jennifer Carroll MacNeill, has said the HSE needs to demonstrate it's in charge of its Budget following a 250 million euro overspend. For the latest, Ronan Mahon, Lecturer in Health Economics at the University of Galway.

As part of the Future of Texas series in partnership with Texas 2036, this episode tackles one of the most urgent and personal challenges facing Texans today: the rising cost of healthcare. Through the Future of Texas podcast series, Texas 2036 brings together diverse perspectives as we explore the opportunities and challenges facing our state over the next ten years. The views expressed in this program are those of the individual speakers and do not necessarily reflect the views of Texas 2036, its staff or its Board of Directors. Host Brad Swail is joined by Avik Roy, Co-Founder and Chairman of FREOPP, and Charles Miller, Director of Health and Economic Mobility Policy at Texas 2036, for a deep dive into why healthcare costs keep rising — and what Texas can actually do about it. The conversation begins with a stark reality: healthcare affordability has become a top concern for voters, even surpassing issues like property taxes. With employer-sponsored family coverage approaching $27,000 per year and out-of-pocket costs averaging around $10,000 annually for Texas families, the financial strain is reshaping both household budgets and business decisions. A major theme is how the current system distorts incentives. Rather than functioning as a true free market, U.S. healthcare operates as a heavily subsidized system where consumers often lack visibility into prices — and have little control over spending decisions. The discussion covers: • Why healthcare costs are rising faster than wages and inflation • How employer-based insurance distorts consumer incentives • The role of federal tax policy in shaping today's system • Why “free market vs government” is a false choice • The importance of competition, transparency, and aligned incentives • How monopoly power among hospitals and providers drives prices higher • Why past reforms — like surprise billing laws — sometimes backfire • The impact of vertical and horizontal consolidation in healthcare • How anti-competitive contracting limits consumer choice • Why Texas has made progress on transparency — but more is needed The episode also explores solutions that could reshape the Texas healthcare landscape. These include expanding price transparency, tackling provider monopolies, enabling more consumer-driven insurance models, and supporting innovative alternatives like direct payment systems and healthcare sharing models. Roy and Miller highlight promising developments already underway in Texas, including efforts to improve data transparency through all-payer claims databases and reforms targeting anti-competitive practices in provider contracts. Looking ahead, the goal isn't perfection — it's progress. Both guests emphasize that simply slowing the growth of healthcare costs to match inflation would represent a major win for Texas families and businesses. The takeaway is clear: the tools to fix healthcare affordability exist — but meaningful reform will require aligning incentives, increasing competition, and taking on entrenched interests within the system. 00:00 — Intro + Future of Texas series overview 00:30 — Why healthcare affordability matters now 01:13 — Cost of employer-sponsored coverage explained 02:00 — National vs Texas-specific cost challenges 03:12 — Texas vs California healthcare cost comparison 04:21 — Why affordability is now a top voter issue 05:21 — 53% cost increase over the past decade 06:41 — Why Texas policy drives higher costs 07:28 — Surprise billing reform and unintended consequences 08:24 — Incentives that drive price inflation 09:53 — Free market vs government: a false debate 10:14 — Why U.S. healthcare isn't truly a free market 11:17 — Employer-based insurance and tax distortions 12:23 — Why consumers don't behave like shoppers 13:23 — What a “healthy market” actually requires 14:17 — Transparency, competition, and incentives explained 15:25 — How subsidies can increase costs 16:09 — Insurance incentives and rising premiums 17:19 — Lack of price transparency in real-world care 17:58 — Switzerland as a model system 19:10 — Competition vs monopoly power in healthcare 20:29 — Real-world example: pricing distortions 21:42 — Hospital consolidation and market power 23:04 — Hospital Competition Act explained 25:02 — Why regulators struggle to fix consolidation 27:08 — Federal vs local enforcement gaps 29:33 — What Texas has done right so far 30:13 — Transparency reforms and data systems 31:05 — Anti-competitive contracting reforms 32:33 — Vertical integration and its risks 34:07 — What Texas still needs to fix 35:14 — Consumer-driven insurance models (ICHRA) 36:01 — Alternatives to traditional insurance 37:26 — Cash pricing and cost savings 38:04 — State employee health plans as a reform lever 40:31 — What success looks like by 2036 42:10 — Slowing cost growth as the first win 43:18 — Final thoughts + closing Watch Full-Length Interviews: https://www.youtube.com/@TexasTalks

Tuesday's program featured our monthly visit with the New Hampshire Insurance Department. Our guest was Dr. Jason Aziz, the Department's Director of Health Economics discussing a recent report from the NHID Data Analytics team and recommendations from Commissioner Bettencourt.

Claim Your Spotlight: How to Rock Courage, Consistency, and Killer Confidence What if the secret to massive success wasn't doing more — but doing less, consistently and strategically? In this powerful episode of the Find Your Leadership Confidence Podcast, Vicki Noethling sits down with Dr. Christiane Schroeter — Business & Wellness Coach, Professor of Marketing, Innovation, and Entrepreneurship, bestselling author, and host of the globally ranked Happy Healthy Hustle Podcast — to uncover how small, focused actions create extraordinary results. With a Ph.D. in Health Economics and national recognition for her academic and entrepreneurial work, Christiane blends data-driven strategy with real-world execution. Her Petite Practice™ framework empowers entrepreneurs to take intentional micro-steps that compound into confidence, clarity, and sustainable business growth. In this conversation, Christiane shares: Her journey from academia to entrepreneurship • The inspiration behind the Petite Practice™ framework • How her podcast climbed into the global top 1% • Lessons from her Amazon #1 book How to Master Your Goals • A preview of her upcoming book Discover Your Superpower • The biggest challenges female entrepreneurs face — and how to overcome them If you’re ready to stop overthinking, step into your spotlight, and build courage through consistency, this episode delivers practical, no-fluff strategies you can apply immediately. Listen in — and claim your spotlight. This link offers listeners a free resource—my “Video Podcast Action Guide.” Learn how to pitch yourself to podcasts effectively with my step-by-step video guide! This resource shows you how to craft a compelling pitch that gets you booked on the right shows to grow your brand and reach your ideal audience. https://quiz.tryinteract.com/#/680acbb35fb6f0001547ba20 Subscribe to Our PodcastConnect With Our Guest Website: https://doctorchristiane.com/ LinkedIn: https://www.linkedin.com/in/christianeschroeter/ Facebook: https://www.facebook.com/Doctor.Christiane/ Instagram: https://www.instagram.com/doctor.christiane Pinterest: https://www.pinterest.com/doctorchristiane/ YouTube: https://www.youtube.com/@doctor.christiane Threads: https://www.threads.com/@doctor.christiane Podcast: happy healthy hustle  The post Christiane Schroeter on Claim Your Spotlight: How to Rock Courage, Consistency, and Killer Confidence first appeared on The Find Your Leadership Confidence Podcast with Victoria Noethling.

Die Themen in den Wissensnachrichten +++ Junge Pottwal-Bullen beim gegenseitigen Kopf-Rammen gefilmt +++ Homeoffice-Abschaffung könnte kontraproduktiv sein +++ Dank Decklack Touchscreen mit langen Fingernägeln bedienen +++**********Weiterführende Quellen zu dieser Folge:Headbutting Behavior Between Sperm Whales Documented Using Unoccupied Aerial Vehicles. Marine Mammal Science, 23.03.2026Zurück ins Büro? - Verbreitung, Hintergründe und Folgen von Return-to-Office-Initiativen. WSI Policy Brief, März 2026Modification of nail polish formulations for conductivity to operate capacitive touchscreens. Poster der ACS SpringWeltwassertag: Erhebliche Zunahme von Trockenheit weltweit, insbesondere in Europa. Meldung vom GFZ Helmholtz-Zentrum für Geoforschung, 21.03.2026Further Findings on the Intergenerational Transmission of Alcohol Consumption. Health Economics, 22.03.2026Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .

John Maytham is joined by Nosiphiwo Nzimande, a researcher with the South African Medical Research Council and the Wits Centre for Health Economics and Decision Science – Priceless SA, who argues that South Africa urgently needs child-centric advertising regulation that prioritises public health and children’s rights in shared public spaces. Afternoon Drive with John Maytham is the late afternoon show on CapeTalk. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30 pm. CapeTalk fans call in to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 to 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Ted Joyce is a Professor of Economics at Baruch College and the Graduate Center, the City University of New York and a Research Associate in the National Bureau of Economic Research's program in Health Economics. He has published extensively in the area economic demography and reproductive health policy.  His work on abortion policy has appeared in the Journal of Political Economy, New England Journal of Medicine, the Journal of the American Medical Association, the Journal of Human Resources and the Review of Economics and Statistics. His most recent work is on the evaluation of programs to improve the academic outcomes of low-income students in higher-education. Dr. Joyce is on the Editorial Board for the Journal of Policy Analysis and Management. Part 2 The discussion included the following topics: the speed at which change can occur; AI impact on higher education institutions and academic health science centers; trends regarding how AI and online learning might influence one another; and emerging ethical questions that must be addressed.    

The lecture examines the various economic, institutional, and political factors that are driving these approaches to health system reform drawing on work by the Partnership for Health System Sustainability and Resilience (www.phssr.org) of which the LSE is a founding partner, and will consider what these mean for health outcomes. The lecture will also reflect on what these developments can reveal about the future direction of health policy in other parts of the Middle East. Meet our speakers Professor Alistair McGuire is the Kuwait Chair of Health Economics at the Department of Health Policy and at the LSE Middle East Centre. Prior to this he was Professor of Economics at City University, London after being a tutor in Economics at the University of Oxford. Professor McGuire has also been a Visiting Professor at Harvard University, the University of Sydney, the University of York, the Universitat of Barcelona and the Universitat Pompeu Fabra Barcelona. George Wharton is Deputy Head of Department (Teaching) Department of Health Policy, with an academic background in International Relations (BSc, LSE) and Health Policy (MSc, Imperial). George's work focuses on a broad range of themes in comparative international health policy. Meet our chair Katerina Dalacoura is Associate Professor in International Relations at the London School of Economics and Political Science, and Director of the LSE Middle East Centre. She held a Major Research Fellowship by the Leverhulme Trust between 2021 and 2024. The project findings will shortly be published as a book monograph by Cambridge University Press, under the title Islamic International Thought in Turkey: History, Civilisation and Nation.

Ted Joyce is a Professor of Economics at Baruch College and the Graduate Center, the City University of New York and a Research Associate in the National Bureau of Economic Research's program in Health Economics. He has published extensively in the area economic demography and reproductive health policy.  His work on abortion policy has appeared in the Journal of Political Economy, New England Journal of Medicine, the Journal of the American Medical Association, the Journal of Human Resources and the Review of Economics and Statistics. His most recent work is on the evaluation of programs to improve the academic outcomes of low-income students in higher-education. Dr. Joyce is on the Editorial Board for the Journal of Policy Analysis and Management. Part 1 The discussion included the following topics: does tension exist between AI and online learning; whether AI transforms online learning into something more effective; role played by AI in measuring student performance; and determining certainty that the work produced by a student is by that individual.      

Global health systems are under pressure. Funding models are shifting. NGOs are closing. Communities are feeling the consequences.On this episode of The Charity Charge Show, host Grayson Harris sits down with Peter Navario, CEO of HealthRight International and professor of health economics at New York University, to discuss what it takes to deliver sustainable healthcare solutions for marginalized communities, both globally and here in the United States.From community-based mental health programs to new funding platforms designed to rethink global health financing, this episode explores what it means to build systems that last.Guest: Peter Navario Title: CEO, HealthRight International | Professor of Health Economics, NYU Topics Covered:The mission and history of HealthRight InternationalThe “triangle” model: community, community health workers, and primary care systemsAddressing mental health through peer-led, evidence-based interventionsWhy traditional one-on-one therapy is not scalableThe impact of foreign aid cuts on global health organizationsHow HealthRight is diversifying revenue and launching a direct investment platformThe need for a better dialogue between funders and implementersAbout Peter NavarioPeter Navario serves as CEO of HealthRight International and is a professor of health economics at NYU.With decades of experience in global health and development, he brings both academic insight and field-based leadership to his role. Under his leadership, HealthRight has focused on strengthening community-based care models and building more sustainable funding mechanisms for long-term health system resilience.

On this episode of SurgOnc Today, Dr. Zhi Ven Fong discusses with Dr. Christopher Childers, Dr. Erin Strong, Dr. Udai Sibia, & Dr. David Litvak, what surgical oncologists should know about value-based care and how it impacts their practices. The speakers also touch on real-world examples and detail how surgical oncologists can take an active role in optimizing value-based care within their hospital and health systems.

Thomas Campanella, a healthcare economist, says, "Our healthcare system is shaped by what you pay for and how you pay for it." At present, it is in terrible shape. How can this system become healthy? Campanella talks with Host Llewellyn King and Co-host Adam Clayton Powell III.

Rural health experts dig into the Trump administration's effort to transform rural health care.Guests:Kevin Bennett, Director Center for Rural & Primary Healthcare; Professor, Family and Preventative Medicine, School of Medicine Columbia, University of South CarolinaPaula Chatterjee, Director of Health Equity Research, Penn LDI; Assistant Professor, Medicine, Perelman School of MedicineSarah Jane Tribble, Chief Rural Correspondent, KFF Health NewsRachel Werner, Executive Director, Leonard Davis Institute of Health Economics; Professor of Medicine, Perelman School of Medicine, University of PennsylvaniaLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

John Maytham speaks to Professor Susan Goldstein, Associate Professor at the SAMRC Centre for Health Economics and Decision Science – PRICELESS, to explore the delicate balance between raising alcohol prices to curb consumption and the risk of fuelling an illegal trade. Professor Goldstein will break down the research, economic mpacts, and potential policy approaches that could make such interventions more effective. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Minister of Climate Change and Environmental Coordination Dr. Musadiq Malik comes on the Pakistan Experience to discuss the Floods, Climate Change, Early Warning Systems, the Hybrid Regime, Balochistan, PTI vs the Writ of the State, Imran Khan's sisters being mishandled, deforestation, accountability, electric vehicles, and more.Dr. Musadik Malik holds a BS in Pharmacy from the University of the Punjab.He then went to University of Illinois, where he earned an MBA, an M.S. and a Ph.D. in Healthcare Administration and Policy.In addition, he completed a post-doctoral fellowship in Health Economics and Medical Decision Making at the University of Illinois College of Medicine.The Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/joinChapters:0:00 Karachi and Motorways6:38 Climate Change, Housing Societies and RUDA25:00 Floods, Early Warning Systems and GLOF34:00 RUDA and Flood prevention Systems44:00 Deforestation, Cutting Trees and Accountability 52:10 Siyaasi Majbooriyan and Petroleum 1:02:12 Balochistan and the Hybrid Regime1:19:00 Military Courts, Institution Strengthening and Writ of the State1:29:40 Imran Khan's sisters being manhandled and writ of the state1:35:20 Gandapur and PTI's incitement to violence1:40:15 Audience Questions

Minister of Climate Change and Environmental Coordination Dr. Musadiq Malik comes on the Pakistan Experience to discuss the Floods, Climate Change, Early Warning Systems, the Hybrid Regime, Balochistan, PTI vs the Writ of the State, Imran Khan's sisters being mishandled, deforestation, accountability, electric vehicles, and more.Dr. Musadik Malik holds a BS in Pharmacy from the University of the Punjab.He then went to University of Illinois, where he earned an MBA, an M.S. and a Ph.D. in Healthcare Administration and Policy.In addition, he completed a post-doctoral fellowship in Health Economics and Medical Decision Making at the University of Illinois College of Medicine.The Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/joinChapters:0:00 Karachi and Motorways6:38 Climate Change, Housing Societies and RUDA25:00 Floods, Early Warning Systems and GLOF34:00 RUDA and Flood prevention Systems44:00 Deforestation, Cutting Trees and Accountability 52:10 Siyaasi Majbooriyan and Petroleum 1:02:12 Balochistan and the Hybrid Regime1:19:00 Military Courts, Institution Strengthening and Writ of the State1:29:40 Imran Khan's sisters being manhandled and writ of the state1:35:20 Gandapur and PTI's incitement to violence1:40:15 Audience Questions

John Maytham speaks to Prof Susan Goldstein, Associate Professor at the SAMRC Centre for Health Economics and Decision Science – PRICELESS. She explains why the idea that alcohol is “not that bad” doesn’t hold up to scientific scrutiny, and why global health bodies now say there is no safe level of alcohol consumption. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Dr. Malina Müller, Head of Health Economics at WifOR Institute, to explore the heated debate around accelerated and conditional approvals in Europe, how demographic and budget pressures shape HTA decisions, the tradeoffs between surrogate endpoints and overall survival, the challenges of using real world evidence under GDPR, and the broader pricing and competitiveness threats facing Europe’s life science ecosystem. Key Topics: Accelerated Approvals: Uncertainty versus early access, conditional pathways in Europe, and costs of delayed treatment. Health System Pressures: Aging populations, fixed-price hospital incentives, cross-country budget constraints. Endpoints & Evidence: Surrogate versus overall survival, patient-reported outcomes, practical limits of real-world evidence in Europe. HTA & Harmonization: Germany's strict assessments, JCA and EMA alignment, and equity gaps across member states. Global Pricing Risks: Most Favored Nation (MFN) proposals, launch delays between the FDA and EMA, and Europe’s competitiveness versus China. Opinions expressed are those of the speakers.See omnystudio.com/listener for privacy information.

Oui, plusieurs études scientifiques ont montré une corrélation entre les pics de pollen dans l'air et une hausse du nombre de suicides. Ce n'est pas une relation de cause à effet directe, mais plutôt un facteur aggravant qui pourrait influencer la santé mentale, surtout chez les personnes déjà fragiles psychologiquement.Une étude publiée en 2025 dans le Journal of Health Economics intitulée « Seasonal allergies and mental health: Do small health shocks affect suicidality? » a analysé plus de dix ans de données aux États-Unis, couvrant 34 zones métropolitaines entre 2006 et 2018. Les chercheurs ont constaté qu'au cours des journées où la concentration de pollen était la plus élevée, le nombre de suicides augmentait d'environ 7,4 % par rapport aux jours où le pollen était au plus bas. Cette hausse atteignait même 8,6 % chez les personnes ayant déjà un suivi pour troubles mentaux. Une autre recherche publiée dans la revue BMJ Open en 2013 en Europe allait dans le même sens, confirmant que les jours de forte pollinisation étaient associés à un risque plus élevé de suicide.Pourquoi cette association ? Plusieurs mécanismes biologiques et psychologiques peuvent l'expliquer. D'abord, les allergies au pollen déclenchent une réaction inflammatoire dans l'organisme : le système immunitaire libère des cytokines et de l'histamine, substances qui peuvent influencer la chimie du cerveau et modifier l'humeur. Certaines études en neurosciences suggèrent que l'inflammation chronique pourrait jouer un rôle dans la dépression. Ensuite, les symptômes physiques liés aux allergies — nez bouché, toux, fatigue, troubles du sommeil — altèrent la qualité de vie et peuvent accentuer l'irritabilité ou la lassitude. À cela s'ajoute un facteur psychologique : au printemps, période souvent associée à la vitalité et au renouveau, certaines personnes souffrant de dépression ressentent un contraste plus fort entre leur état intérieur et le monde extérieur, ce qui peut accentuer leur détresse.Il faut cependant rester prudent : le pollen ne “provoque” pas le suicide. C'est un facteur parmi d'autres qui peut fragiliser l'équilibre psychique, notamment chez les individus vulnérables. Les chercheurs parlent d'un “petit choc environnemental”, un élément supplémentaire qui peut, dans certaines circonstances, faire basculer quelqu'un déjà en difficulté.En résumé, les jours où le taux de pollen est très élevé coïncident souvent avec une légère hausse des suicides. Le phénomène s'expliquerait par les effets combinés de l'inflammation, du manque de sommeil et de la vulnérabilité émotionnelle. Une donnée que la recherche en santé mentale commence désormais à prendre au sérieux. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Creativity through the lens of podcast host, Ted X speaker and author "Each of us have a way to show our super power, and each of us have a way to tie creativity to our super power."Dr. Christiane Schroeter is a TEDx speaker, Business & Wellness Coach, Professor, and bestselling author who helps entrepreneurs achieve big results through small, strategic actions.With a Ph.D. in Health Economics, she is a Professor of Marketing, Innovation, and Entrepreneurship at a top-ranked U.S. university, earning national and international recognition for her work. Christiane blends academic expertise with real-world strategy, offering podcast audiences practical insights they can use immediately.As the host of the Happy Healthy Hustle Podcast, ranked in the Top 1% globally, she shares high-performance strategies that integrate productivity, business growth, and well-being. Her no-fluff, high-energy approach makes her a memorable guest who connects deeply with driven, purpose-led audiences.She has built a thriving, loyal community on Instagram and YouTube, where she shares results-driven content for professionals committed to sustainable success.Christiane is the author of three books, including the bestselling How to Master Your Goals, which debuted as an Amazon #1 New Release in Adult Education. Her latest releases, Discover Your Superpower and the companion Petite Practice™ Planner, build on her signature Petite Practice™ framework. This system empowers entrepreneurs to work smarter, scale faster, and lead with clarity and confidence.A sought-after keynote speaker, Christiane delivers engaging, actionable conversations grounded in research and designed to spark meaningful transformation.https://doctorchristiane.com/https://www.linkedin.com/in/christianeschroeter/https://www.instagram.com/doctor.christianehttps://www.threads.com/@doctor.christianehttps://www.tiktok.com/@hello.happy.nesthttps://tinyurl.com/DoctorCShttps://www.youtube.com/@doctor.christianehttps://www.pinterest.com/doctorchristiane/https://www.facebook.com/Doctor.Christiane/https://open.spotify.com/playlist/1StxXZwOlq6sY0hNATqa5D?si=_Cy0jJ2rTPWD913Bj1eirw&nd=1&dlsi=a70921b98b244dc3https://doctorchristiane.com/quizSend us a text

Dr. Frank Leone is a Professor of Medicine in the Perelman School of Medicine, University of Pennsylvania. He directs Penn's Comprehensive Smoking Treatment Program, offering multidisciplinary collaborative patient care to people suffering complex manifestations of tobacco use disorder. Dr. Leone is a Senior Fellow of the Leonard Davis Institute of Health Economics. His scholarship focuses on investigating advanced treatment strategies for tobacco use disorder and on testing strategies for improving the care of the tobacco dependent patient. Dr. Leone has published over 130 peer-reviewed papers and, along with Ms. Evers-Casey, has co-authored a clinical handbook of tobacco dependence treatment titled Why People Smoke: An Innovative Approach to Treating Tobacco Dependence. Today on the show we discuss: why vaping isn't actually safer than cigarettes, how vape aerosols damage your lungs and heart even without traditional carcinogens, the hidden addiction mechanics that make nicotine one of the hardest habits to break, why vaping increases anxiety, depression, and the risk of other substance addictions, how to finally quit vaping for good  proven strategies, how parents and loved ones can help without judgment or shame and much more. ⚠ WELLNESS DISCLAIMER ⚠ Please be advised; the topics related to health and mental health in my content are for informational, discussion, and entertainment purposes only. The content is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek the advice of your health or mental health professional or other qualified health provider with any questions you may have regarding your current condition. Never disregard professional advice or delay in seeking it because of something you have heard from your favorite creator, on social media, or shared within content you've consumed. If you are in crisis or you think you may have an emergency, call your doctor or 911 immediately. If you do not have a health professional who is able to assist you, use these resources to find help: Emergency Medical Services—911 If the situation is potentially life-threatening, get immediate emergency assistance by calling 911, available 24 hours a day. National Suicide Prevention Lifeline, 1-800-273-TALK (8255) or https://suicidepreventionlifeline.org.  SAMHSA addiction and mental health treatment Referral Helpline, 1-877-SAMHSA7 (1-877-726-4727) and https://www.samhsa.gov Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome back to this explainer on health economics analyses in musculoskeletal rehabilitation. In part 1, Dr Codie Primeau explained the things you're looking for when reading a health economics analysis, to decide whether it's a good quality analysis. That's important because a good quality analysis can help you make decisions about whether the intervention being studied is worth considering. Today in part 2, we take things a step further to explore how you decide what "worthwhile" really means. Worth it for whom? The patient, your clinic, the health system, or even society? ------------------------------ RESOURCES From whose perspective is cost-effectiveness judged?: https://pmc.ncbi.nlm.nih.gov/articles/PMC6351264/ Review of health economics evaluations in hip and knee orthopaedics: https://pubmed.ncbi.nlm.nih.gov/34262974/

Whether you work in a solo private practice, or a large health network, no doubt you're considering costs when it comes to deciding what to change and perhaps what to implement - or de-implement - in your practice. Perhaps you're in the position of making decisions on behalf of a health service or you are trying to quantify and communicate the costs and benefits of treatments you study in a research setting? Today is part 1 of a 2-part chat with Dr Codie Primeau about health economics in musculoskeletal rehabilitation, which has something for everyone working in health care. We're covering how to read a health economics analysis to decide whether the analysis can help you navigate the complex decisions you're grappling with. Dr Primeau is a physiotherapist and Assistant Professor in the School of Physical Therapy at Western University in London, Canada, and an Affiliate Scientist with Arthritis Research Canada. His research focuses on arthritis, chronic pain, and pelvic health, using a blend of qualitative and quantitative methods to improve patient care and outcomes, including health economics evaluation. ------------------------------ RESOURCES From whose perspective is cost-effectiveness judged?: https://pmc.ncbi.nlm.nih.gov/articles/PMC6351264/ Review of health economics evaluations in hip and knee orthopaedics: https://pubmed.ncbi.nlm.nih.gov/34262974/

On this episode of Alloutcoach, host Tim Mikhelashvili, CEO, Amedea Pharma convenes a panel you rarely hear in one room: a policy-minded biohacker and investor (John Hemming, CEO of Cirrostratus, Biohacking Team Leader), a strategy and operations leader who reshapes patient journeys (Bart Zoni, Senior Vice President, Marketing, Woven Health Collective), and an early-stage investor focused on medical technologies (Chris Piedmonte, Managing Director, Neoterra Capital) as well as a senior pharma thought leader in Medical Affairs and Health Economics, Janelle Hardisty. Their catalyst? Fresh takeaways from the 2025 Financial Times US Pharma summit — and an honest look at what's truly accelerating innovation, what's stalling it, and where capital and talent should go next.00:00:00 Cold Open - Episode Highlights: AI accuracy and access00:03:43 Host Intro and Why This Episode00:04:41 Guest Intros00:08:06 State of Innovation - Tailwinds and Headwinds00:12:41 What's Really Accelerating Innovation?00:19:27 Drug Discovery - Reducing the 90% Failure Rate00:22:01 Clinical Trials - Modernize or Stall00:25:11 Access, PBMs, and Direct-to-Patient00:27:03 Longevity and Prevention - Can We Measure It?00:36:52 Data Culture Maturity and Pilot Fatigue00:45:52 Training the Future Workforce00:51:09 Investing - Where Should Capital Flow?00:57:08 Regulatory Reality and Time-to-Access00:59:27 Closing and Invite to Medical Innovation Olympics

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial payers. HEOR, viewed as a strategic lever as opposed to a compliance exercise, can help answer investor questions about market differentiation, pricing pathways, and real world product validation. Abbott talks about the value of cost-of-illness studies, burden-of-disease analyses, and payer landscape assessments, and how AI, real world evidence, and patient-centered research can improve drug and trial design and accelerate market access.       Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

 Today we joined by Jon Gordon, a visionary, thinker, and innovator working at the crossroads of healthcare, finance and consciousness. Jon brings over a decade of experience in the healthcare industry, spanning strategy consulting for hospitals and health systems, payer business strategy, medical product management, and startup development, while also being deeply rooted in yoga.Holistic wellness and the emerging paradigm of decentralized finance. Jon is a graduate of Northwestern University with a BA in Economics, and he went on to earn a double Master's in Health Economics and Policy at both the University of Chicago and the London School of Economics. Alongside his academic and professional expertise, Jon is also a certified Himalayan Kriya yoga teacher and an author exploring the profound connections between Bitcoin and yoga.For the past four years, Jon has immersed himself in the Bitcoin space, not just as a student of financial systems, but as a community builder and Austin's vibrant Bitcoin scene. He also has co-founded two ventures at the intersection of Bitcoin and healthcare, re-imagining how money and medicine can work together for collective wellbeing.This conversation, Jon and Sasha explore: The 80-year cycle of finance and the lessons it offers us today Bitcoin as a decentralized store of value and a potential game changer for time, health, and human empowermentHow embracing change and deepening financial literacy can help us prepare for the future of currencyThe integration of Bitcoin into healthcare, including Ayurveda, Yoga teacher trainings and other holistic practices People may want to invest in the vision of a new paradigm where money and health merge, creating a reality where value exchange supports both healing and human flourishing. This is a powerful conversation at the frontier of Ayurveda, yoga, and financial evolution; a reminder that the way we think about money is inseparable from the way that we think about our health, our time, and our freedom. Send us a textFor 20% off Kerala Ayurveda products, use code OjasOasis at checkoutFor 20% off GarryNSun products, use code OJASOASIS20 at checkout Book a 1:1 with Sasha at https://www.ojasoasis.com/book For 50% off your initial intake consultation, mention you're a subscriber of the podcast. Support the showTo learn more about working with us, please visit www.OjasOasis.com Connect with us @ojasoasis on Instagram

What happens when a single bill threatens to leave 10+ million Americans uninsured and hospitals on the brink?In this episode, host Dr. Bradley Block reunites with Adam Block, PhD, to break down Trump's sweeping healthcare legislation, HR 1—dubbed the "big beautiful bill"—which consolidates multiple reforms into one massive package. He explains how indirect measures like increased paperwork, monthly re-enrollments, and work requirements will lead to 10+ million losing Medicaid and ACA coverage, without direct cuts. The discussion covers fraud, waste, and abuse in Medicaid, the role of AI in filling government gaps, and the bill's delayed rollout post-midterms. They also explore site-neutral payments' effects on hospitals and ambulatory centers, cross-subsidization for safety-net services, and why hospitals' razor-thin margins make them vulnerable. This episode is crucial for healthcare professionals preparing for higher uncompensated care, sicker patients, and systemic shifts in reimbursement and access.Three Actionable Takeaway:Monitor Policy Changes Closely – Stay informed on Medicaid work requirements and ACA enrollment shifts rolling out in 2027. Review your practice's payer mix and prepare for increased uninsured patients by advocating for state-level expansions or adjustments.Advocate for Your Practice – If you own or operate ambulatory surgery centers, assess the impact of site-neutral payments. Engage with hospital associations to push for subsidies that maintain safety-net services, ensuring cross-subsidization doesn't erode entirely.Prepare for Operational Strain – Anticipate higher uncompensated care and sicker presentations. Build contingency plans like AI-assisted administrative tools or partnerships with community resources to handle paperwork burdens and support vulnerable patients.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Adam Block is a Harvard-trained health economist with over two decades of experience at the intersection of healthcare policy, hospitals, and insurance. He played a key role in drafting sections of the Affordable Care Act for Congress and writing foundational regulations for the Centers for Medicare & Medicaid Services (CMS) to establish health insurance exchanges. After five years in data analytics roles reporting to CFOs, he founded Charm Economics, a consulting firm focused on health economics, and serves as an associate professor of public health at New York Medical College. Dr. Block's expertise lies in navigating complex policy changes, reimbursement challenges, and systemic healthcare shifts, offering critical insights for physicians and providers.LinkedIn: linkedin.com/in/adameblockEmail: adam@charmeconomics.comWebsite: https://www.charmeconomics.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance.

Dr. Christiane Schroeter is a TEDx speaker, bestselling author, and Business & Wellness Coach who helps entrepreneurs achieve extraordinary results with small, strategic actions. With a Ph.D. in Health Economics, she is a Professor of Marketing, Innovation, and Entrepreneurship at a top U.S. university and has earned international recognition for her research and teaching.She is the host of the Happy Healthy Hustle Podcast—ranked in the Top 1% globally—where she shares high-performance strategies that blend productivity, business growth, and well-being. Her no-fluff, high-energy style makes her a memorable and practical guest for purpose-driven audiences.Christiane is the author of three books, including the Amazon #1 bestseller How to Master Your Goals. Her signature Petite Practice™ framework, featured in her latest releases Discover Your Superpower and the Petite Practice™ Planner, empowers entrepreneurs to work smarter, scale faster, and lead with clarity. A sought-after keynote speaker, she delivers actionable insights designed to spark meaningful transformation.

Best-selling author, speaker & creator of “The PetitePractice” Dr. Christiane Schroeter talks about her releases “Discover YourSuperpower” and “How to Master Your Goals” helping professionals andentrepreneurs unlock their unique strengths & create success on their ownterms! Dr. Schroeter began her career moving from Germany to the U.S. in '99while earning her degrees in Health Economics and Agribusiness, began “The PetitePractice” as a way to grow honoring your energy, season, and pace; plusexplains the 3P System and how to stop overthinking & start making progresswhile taking action and building confidence creating momentum in your life andcareer! Check out the amazing Dr. Christiane Schroeter and her latest releaseon all major platforms and www.doctorchristiane.comtoday! #podmatch #drchristianeschroeter #author #creator #thepetitepractice#discoveryoursuperpower #howtomasteryourgoals #professionals #enterpreneurs#economics #agriculture #germany #3Psystem #energy #spreaker #iheartradio#spotify #applemusic #youtube #anchorfm #bitchute #rumble #mikewagner#themikewagnershow #mikewagnerdrchristianeschroeter #themikewagnershowdrchristianeschroeter

The One Big Beautiful Bill Act is projected to cut Medicaid spending by more than $1 trillion. The law changes eligibility rules, and some predictions estimate at least 10.5 million people will be eliminated from the program. “For some adults, Medicaid will step in and help pay for care at home, or if care at home is not available, for care in nursing homes,” said Rachel Werner, executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. “With the cuts to Medicaid funding, we are expecting that the availability of care in both of those settings will diminish, and it will be harder for people to get the care they need to live independently.” States will have to respond to the changes by either making up the funding gap or reducing services. On the show today, Werner explains how the funding cuts could limit the caregiving options for older Americans who need at-home care and place a larger responsibility on their families. Plus, we discuss how to start planning for long-term care amid all the legislative changes.Then, we'll celebrate a listener's win about her chocolate lab puppy. And, another listener's quest to find life on Mars.Here's everything we talked about today:“How Medicaid Cuts Could Force Millions Into Nursing Homes” from The Leonard Davis Institute of Health Economics at the University of Pennsylvania“Advocates warn that Medicaid cuts in the big budget law put home-based health care at risk” from Marketplace“New AARP Report: Majority of Adults 50-plus Want to Age in Place, But Policies and Communities Must Catch Up” from AARP“A Closer Look at the Medicaid Work Requirement Provisions in the “Big Beautiful Bill” from KFF“Medicaid cuts: The how and why” from the newsletter Your Local Epidemiologist“As the need for nursing homes grows, nurses are in short supply” from MarketplaceWe love hearing from you. Leave us a voicemail at 508-U-B-SMART or email makemesmart@marketplace.org.

The One Big Beautiful Bill Act is projected to cut Medicaid spending by more than $1 trillion. The law changes eligibility rules, and some predictions estimate at least 10.5 million people will be eliminated from the program. “For some adults, Medicaid will step in and help pay for care at home, or if care at home is not available, for care in nursing homes,” said Rachel Werner, executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. “With the cuts to Medicaid funding, we are expecting that the availability of care in both of those settings will diminish, and it will be harder for people to get the care they need to live independently.” States will have to respond to the changes by either making up the funding gap or reducing services. On the show today, Werner explains how the funding cuts could limit the caregiving options for older Americans who need at-home care and place a larger responsibility on their families. Plus, we discuss how to start planning for long-term care amid all the legislative changes.Then, we'll celebrate a listener's win about her chocolate lab puppy. And, another listener's quest to find life on Mars.Here's everything we talked about today:“How Medicaid Cuts Could Force Millions Into Nursing Homes” from The Leonard Davis Institute of Health Economics at the University of Pennsylvania“Advocates warn that Medicaid cuts in the big budget law put home-based health care at risk” from Marketplace“New AARP Report: Majority of Adults 50-plus Want to Age in Place, But Policies and Communities Must Catch Up” from AARP“A Closer Look at the Medicaid Work Requirement Provisions in the “Big Beautiful Bill” from KFF“Medicaid cuts: The how and why” from the newsletter Your Local Epidemiologist“As the need for nursing homes grows, nurses are in short supply” from MarketplaceWe love hearing from you. Leave us a voicemail at 508-U-B-SMART or email makemesmart@marketplace.org.

On June 18, Tradeoffs moderated an online event with economists and doctors examining why this legislation could cost so many people their health coverage — or even their lives.Guests:Eric Roberts, Associate Professor, Department of General Internal Medicine, Perelman School of MedicineAditi Vasan, Assistant Professor, Department of Pediatrics, Perelman School of MedicineRachel Werner, Executive Director, Leonard Davis Institute of Health Economics, University of PennsylvaniaLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.